Integrated Wealth Management (Palm Desert)’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-12
Closed – – 1236
2016
Q3
$0 Hold
12
– – ﹤0.01% 1365
2016
Q2
$0 Hold
12
– – ﹤0.01% 1419
2016
Q1
$0 Hold
12
– – ﹤0.01% 1386
2015
Q4
$0 Hold
12
– – ﹤0.01% 1437
2015
Q3
$0 Hold
12
– – ﹤0.01% 1435
2015
Q2
$0 Hold
12
– – ﹤0.01% 1538
2015
Q1
$0 Buy
+12
New +$305 ﹤0.01% 1413

Integrated Wealth Management (Palm Desert)'s AEGR Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 12 shares.

Integrated Wealth Management (Palm Desert) first reported a position in AEGR in Q1 2015 and held it in 7 quarters. The position peaked at $0 in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 12 Aegerion Pharmaceuticals shares in Q4 2016.
  • Integrated Wealth Management (Palm Desert) first reported a position in Aegerion Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Integrated Wealth Management (Palm Desert)'s Aegerion Pharmaceuticals position peaked at $0 in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.